Padraig Andrew O'Connor - Dec 1, 2025 Form 3 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP, Global Operations
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Dec 1, 2025
Transactions value $
$0
Form type
3
Date filed
12/8/2025, 04:49 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Connor Padraig Andrew EVP, Global Operations 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 2025-12-08 0002098740

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BSX Common Stock 3.89K Dec 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BSX Restricted Stock Units Dec 1, 2025 Common Stock 3.17K Direct F1, F2, F3
holding BSX Restricted Stock Units Dec 1, 2025 Common Stock 2K Direct F3, F4
holding BSX Restricted Stock Units Dec 1, 2025 Common Stock 2.38K Direct F3, F5, F6
holding BSX Restricted Stock Units Dec 1, 2025 Common Stock 905 Direct F3, F7, F8
holding BSX Restricted Stock Units Dec 1, 2025 Common Stock 1.8K Direct F3, F9, F10
holding BSX Restricted Stock Units Dec 1, 2025 Common Stock 4.69K Direct F3, F11
holding BSX Stock Option (Right to Buy) Dec 1, 2025 Common Stock 13.8K $37.50 Direct F12
holding BSX Stock Option (Right to Buy) Dec 1, 2025 Common Stock 12.1K $44.19 Direct F13
holding BSX Stock Option (Right to Buy) Dec 1, 2025 Common Stock 14.3K $47.28 Direct F14
holding BSX Stock Option (Right to Buy) Dec 1, 2025 Common Stock 13K $64.99 Direct F15
holding BSX Stock Option (Right to Buy) Dec 1, 2025 Common Stock 5.15K $106.14 Direct F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F2 This amount represents the unvested portion of RSUs awarded on February 12, 2024, which will continue to vest in three remaining installments on the anniversary of the date of grant.
F3 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F4 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F6 This amount represents the unvested portion of RSUs awarded on February 14, 2023, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F8 This amount represents the unvested portion of RSUs awarded on February 16, 2022, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F9 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.
F10 This amount represents the unvested portion of RSUs awarded on May 2, 2022, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F11 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on September 2, 2026, the first anniversary of the date of grant.
F12 Grant to the reporting person of an option to purchase 13,822 shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F13 Grant to the reporting person of an option to purchase 12,050 shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F14 Grant to the reporting person of an option to purchase 14,290 shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F15 Grant to the reporting person of an option to purchase 12,998 shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F16 Grant to the reporting person of an option to purchase 5,151 shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant.

Remarks:

oconnorpoa.txt